AIM
GILD icon

Acuity Investment Management’s Gilead Sciences GILD Stock Holding History

Acuity Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-466
Closed -$50K – 163
2014
Q3 		$50K Hold
466
– – 0.04% 143
2014
Q2 		$39K Sell
466
-834
-64% -$64.9K 0.03% 149
2014
Q1 		$92K Sell
1,300
-1,500
-54% -$118K 0.05% 125
2013
Q4 		$211K Buy
+2,800
New +$195K 0.08% 114

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Acuity Investment Management's GILD Position: Q4 2014 in Review

Acuity Investment Management sold out of Gilead Sciences (GILD) in Q4 2014, closing a stake of 466 shares — an estimated $50K sold.

Acuity Investment Management first reported a position in GILD in Q4 2013 and held it in 4 quarters. The position peaked at $211K in Q4 2013. 1,438 funds tracked by Wall St. Rank hold GILD as of Q4 2014.

  • Acuity Investment Management reported no remaining Gilead Sciences position as of Q4 2014 after selling out during the quarter.
  • Acuity Investment Management sold 466 Gilead Sciences shares in Q4 2014, an estimated $50K.
  • Acuity Investment Management first reported a position in Gilead Sciences in Q4 2013 and held it in 4 quarters.
  • Acuity Investment Management's Gilead Sciences position peaked at $211K in Q4 2013.
  • 1,438 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2014.

Based on Acuity Investment Management's 13F filing for Q4 2014, filed 4 Feb 2015.